Related Experiment Video
Updated: Sep 10, 2025

10:26
Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
Published on: May 19, 2023
2.0K
Characterizing the Impact of Training Data on Generalizability: Application in Deep Learning to Estimate Lung Nodule
Bogdan Obreja1, Joeran Bosma1, Kiran Vaidhya Venkadesh1
1Department of Medical Imaging, Radboud University Medical Center, Geert Grooteplein Zuid 10, 525 GA Nijmegen, the Netherlands.
Radiology. Artificial Intelligence
|August 20, 2025
Summary
A deep learning AI effectively assesses pulmonary nodule malignancy risk. Excellent performance was achieved using only a fraction of the training data, reaching peak results before full dataset utilization.
Area of Science:
- Artificial intelligence in medical imaging
- Machine learning for disease detection
- Radiology and oncology research
Background:
- Pulmonary nodules on low-dose CT scans require accurate malignancy risk assessment for lung cancer screening.
- Deep learning algorithms show promise in improving diagnostic accuracy.
- Understanding the impact of training data volume is crucial for AI development.
Purpose of the Study:
- To investigate the relationship between training data volume and the performance of a deep learning AI for pulmonary nodule malignancy risk assessment.
- To determine the minimum training data required for AI performance to be non-inferior to models trained on full datasets and to clinician performance.
Main Methods:
- Retrospective study using 16,077 annotated nodules from the National Lung Screening Trial (NLST).
- Systematic training of a deep learning AI algorithm on stratified NLST data subsets (1.25% to 100%).
- External validation using the Danish Lung Cancer Screening Trial (DLCST) data for performance comparison.
Main Results:
- The AI achieved a mean AUC of 0.92 on the DLCST cohort when trained on the full NLST dataset.
- Non-inferior performance was maintained with 80% of NLST training data (mean AUC 0.92).
- Clinician-level performance (mean AUC 0.82) was achieved with only 20% of the training data on a size-matched DLCST subset.
Conclusions:
- Deep learning AI demonstrates excellent performance in assessing pulmonary nodule malignancy risk.
- Clinical-level performance can be achieved with significantly less training data than initially anticipated.
- Peak AI performance was reached before utilizing the entire available training dataset.
Keywords:
CTConvolutional Neural Network (CNN)Deep LearningDiagnosisLungLung Cancer ScreeningPulmonary Nodule Malignancy RiskPulmonary Nodule ManagementScreeningSupervised Learning
